CRP and hydrops fetalis: The use of anti-inflammatory medications in HF has been prompted by the recent finding that abnormally high levels of specific inflammatory biomarkers (e.g., NT-proBNP, CRP, pentraxin 3, and a combination of other serum markers) might predict future cardiovascular events.